Titel

Merkliste
1 Ergebnisse

Rituximab versus cyclophosphamide for the treatment of conn..:

Saunders, P ; Tsipouri, V ; Keir, GJ...
https://discovery.ucl.ac.uk/id/eprint/1563855/7/Denton_Rituximab%20versus%20cyclophosphamide%20for%20the%20treatment%20of%20connective%20tissue%20disease-associated%20interstitial%20lung%20disease%20%28RECITAL%29_VoR%20%281%29.pdf. , 2017

Link: https://discovery.ucl.ac.uk/id/eprint/1563855/7/Denton..

RT Journal
T1 <Title>Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:1563855&Exemplar=1&LAN=DE
				
A1 Saunders, P
A1 Tsipouri, V
A1 Keir, GJ
A1 Ashby, D
A1 Flather, MD
A1 Parfrey, H
A1 Babalis, D
A1 Renzoni, EA
A1 Denton, CP
A1 Wells, AU
A1 Maher, TM
PB BIOMED CENTRAL LTD
YR 2017
K1 Myositis
K1 Scleroderma
K1 Mixed connective tissue disease
K1 Pulmonary fibrosis
K1 Respiratory failure
K1 Biomarkers
JF https://discovery.ucl.ac.uk/id/eprint/1563855/7/Denton_Rituximab%20versus%20cyclophosphamide%20for%20the%20treatment%20of%20connective%20tissue%20disease-associated%20interstitial%20lung%20disease%20%28RECITAL%29_VoR%20%281%29.pdf
LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/1563855/7/Denton_Rituximab%20versus%20cyclophosphamide%20for%20the%20treatment%20of%20connective%20tissue%20disease-associated%20interstitial%20lung%20disease%20%28RECITAL%29_VoR%20%281%29.pdf
DO https://discovery.ucl.ac.uk/id/eprint/1563855/7/Denton_Rituximab%20versus%20cyclophosphamide%20for%20the%20treatment%20of%20connective%20tissue%20disease-associated%20interstitial%20lung%20disease%20%28RECITAL%29_VoR%20%281%29.pdf
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)